Inventor · disambiguated record
Joseph Lehar
Also filed as: LEHAR JOSEPH
3 granted patents·19 pending applications·19 citations·filing 2002–2023
64Inventor score
Top patents by PatentIndex Score
22 records- 0186US10328066B2Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the CDK4/6 inhibitor ribociclib, and the use thereof in the treatment/prevention of cancerNOVARTIS AG·Filed 2016·Granted Jun 25, 2019·5 cites·2 claims
- 0278US8475804B2Compositions and methods for treatment of filovirus-mediated diseasesJOHANSEN LISA M·Filed 2010·Granted Jul 2, 2013·14 cites·4 claims
- 0371US2022280523A1Combination of pi3k inhibitor and c-met inhibitorNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0470US2023398115A1Mdm2 inhibitors and combinations thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0563US2020253980A1Combination of pi3k inhibitor and c-met inhibitorNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0661US2021260059A1Mdm2 inhibitors and combinations thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0761US2019350935A1Combination of PI3K inhibitor and c-MET inhibitorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0859US2019083500A1Combination of PI3K Inhibitor and C-Met InhibitorNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0959US2005090992A1Using multiple perturbations to elucidate connectivity in network systemsFiled 2004·Application pending·0 cites
- 1057US2021186973A1Combination of ribociclib and dabrafenib for treating or preventing cancerNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1154US2019060309A1Mdm2 inhibitors and combinations thereofNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1251US2015216870A1Combination of PI3K Inhibitor and C-Met InhibitorCAPONIGRO GIORDANO·Filed 2013·Application pending·0 cites
- 1347US2013289024A1Compositions and methods for treatment of filovirus-mediated diseasesJOHANSEN LISA M·Filed 2013·Application pending·0 cites
- 1445US2003152972A1Gene expression associated with psychiatric disordersWHITEHEAD BIOMEDICAL INST·Filed 2002·Application pending·0 cites
- 1545US2004253642A1System and method for multidimensional evaluation of combinations of compositionsFiled 2004·Application pending·0 cites
- 1645US2004253627A1System and method for multidimensional evaluation of combinations of compositionsFiled 2004·Application pending·0 cites
- 1744US2018250302A1Combination of ribociclib and dabrafenib for treating or preventing cancerCAPONIGRO GIORDANO·Filed 2016·Application pending·0 cites
- 1839US2018318275A1Combination therapy using pi3k inhibitor and mdm2 inhibitorNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1936US10328065B2Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the B-RAF inhibitor dabrafenib; the use of such combination in the treatment or prevention of cancerNOVARTIS AG·Filed 2016·Granted Jun 25, 2019·0 cites·3 claims
- 2034US2018243304A1Pharmaceutical combinations comprising (a) the cyclin dependent kinase 4/6 (cdk4/6) inhibitor lee011 (=ribociclib), and (b) the epidermal growth factor receptor (egfr) inhibitor erlotinib, for the treatment or prevention of cancerNOVARTIS AG·Filed 2016·Application pending·0 cites
- 2134US2019365741A1Combinations of the cdk4/6 inhibitor lee011 and the mek1/2 inhibitor trametinib, optionally further comprising the pi3k inhibitor byl719 to treat cancerNOVARTIS AG·Filed 2016·Application pending·0 cites
- 2230US2018256557A1Pharmaceutical combination comprising (a) the alpha-isoform specific pi3k inhibitor alpelisib (byl719) and (b) an akt inhibitor, preferably mk-2206, afuresertib or uprosertib, and the use thereof in the treatment/prevention of cancerCAPONIGRO GIORDANO·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Lehar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →